These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 15201658

  • 1. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.
    Levy G, Villamil F, Samuel D, Sanjuan F, Grazi GL, Wu Y, Marotta P, Boillot O, Muehlbacher F, Klintmalm G, LIS2T Study Group.
    Transplantation; 2004 Jun 15; 77(11):1632-8. PubMed ID: 15201658
    [Abstract] [Full Text] [Related]

  • 2. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 15; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 4. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.
    Liver Transpl; 2005 Nov 15; 11(11):1395-402. PubMed ID: 16237691
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.
    Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352
    [Abstract] [Full Text] [Related]

  • 6. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Liver Transpl; 2008 Feb 27; 14(2):173-80. PubMed ID: 18236391
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
    Krämer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuño J, Sester U, Kunzendorf U, Dietl KH, Bonomini V, Rigotti P, Ronco C, Tabernero JM, Rivero M, Banas B, Mühlbacher F, Arias M, Montagnino G, European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2008 Jul 27; 23(7):2386-92. PubMed ID: 18258740
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.
    Vincenti F, Tuncer M, Castagneto M, Klinger M, Friman S, Scheuermann EH, Wiecek A, Russ GR, Martinek A, Nonnast-Daniel B, DIRECT Study Group.
    Transplant Proc; 2005 Mar 27; 37(2):1001-4. PubMed ID: 15848604
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
    Bechstein WO, Malaise J, Saudek F, Land W, Fernandez-Cruz L, Margreiter R, Nakache R, Secchi A, Vanrenterghem Y, Tydén G, Van Ophem D, Berney T, Boucek P, Landgraf R, Kahl A, Squifflet JP, EuroSPK Study Group.
    Transplantation; 2004 Apr 27; 77(8):1221-8. PubMed ID: 15114089
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
    Vincenti F, Rostaing L, DIRECT (Diabetes Incidence after REnal Transplantation: Neoral C2 monitoring versus Tacrolimus) investigators.
    Contemp Clin Trials; 2005 Feb 27; 26(1):17-24. PubMed ID: 15837449
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients.
    Silva HT, Yang HC, Meier-Kriesche HU, Croy R, Holman J, Fitzsimmons WE, First MR.
    Transplantation; 2014 Mar 27; 97(6):636-41. PubMed ID: 24521771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.